|1.||Kuchmerovs'ka, T M: 2 articles (03/2003 - 11/2001)|
|2.||Donchenko, H V: 2 articles (03/2003 - 11/2001)|
|3.||Loran, O B: 1 article (11/2013)|
|4.||Guseva, N B: 1 article (11/2013)|
|5.||Nikitin, S S: 1 article (11/2013)|
|6.||Vishnevskiĭ, E L: 1 article (11/2013)|
|7.||Gvetadze, A A: 1 article (01/2012)|
|8.||Egorov, E A: 1 article (01/2012)|
|9.||Vinogradova, E P: 1 article (01/2012)|
|10.||Akopian, V P: 1 article (07/2010)|
|1.||Amnesia (Dissociative Amnesia)
|2.||Brain Edema (Cerebral Edema)
01/01/1984 - "Experiments on rats were made to study the action of the derivatives of benzodiazepine (diazepam, 0.5 mg/kg and phenazepam, 0.1 mg/kg), and GABA (phenibut, 50 mg/kg, pantogam, 160 mg/kg, nicotinoyl-GABA, 500 mg/kg, piracetam, 1000 mg/kg) on the development of a traumatic brain edema. "
|3.||Parkinsonian Disorders (Parkinsonism)
11/01/1998 - "Thus, NAm and nicotinoyl-GABA are involved in the regulation of the processes in the brain under experimental parkinsonism."
11/01/1998 - "[Neurotrophic action of nicotinamide and nicotinoyl-GABA in rat brain in experimental Parkinsonism]."
11/01/2001 - "Thus, NAm, nicotinoyl-GABA and NAD are involved in the regulation of brain neurotransmission under experimental parkinsonism and can be useful in treatment of Parkinson's disease."
|4.||Photophobia (Light Sensitivity)
10/01/1994 - "Administration of pikamilon, a cerebrovascular and nootropic drug, to patients with primary open-angle glaucoma with normalized intraocular pressure and declining visual function resulted in improvement of the central and peripheral visual fields manifesting by improvement of individual sensitivity threshold, decreased area and intensity of scotomas; the treatment had a favorable effect on light sensitivity and vision acuity in some patients. "
07/01/2010 - "However, the injection of picamilon under the conditions of 15-day hypokinesia and 8-day recovery period showed a tendency to restoration of the number of active GABA(A) receptors."
07/01/2010 - "The influence of picamilon and piracetam on the quantitative changes in the central GABA(A) macromolecular receptor complexes in the rat brain has been investigated under the experimental conditions of hypokinesia. "
|1.||pantogab (hopantenic acid)
|2.||4-amino-3-phenylbutyric acid (phenibut)
|4.||Sodium Oxybate (gamma Hydroxybutyrate)
|7.||gamma-Aminobutyric Acid (GABA)